India's current research scene is at an inflexion point: Dr Satish Prasad Rath
India's current research scene is at an inflexion point. Intellectual Property (IP) filing from academia and start-ups are rising and so is the same from med-tech, pharmaceutical corporate research houses, said Dr. Satish Prasad Rath, chief of innovation, Aster Innovation and Research Centre.
The country's research activities are in a phase to translate these IPs to sustainable businesses. This can be done through open innovation in collaborative model. The objective is to position ourselves as a potent catalyst in this changing scenario, he added.
Some of the visible trends that one sights in this space are newer inventions like affordable cloud, connectivity, Internet of Things (IoT) that are making preventive and out-of-hospital care a reality. It is important to note that it should be technically feasible. Appropriate applications of this will make this a business reality too. So far hospitals have been using the technologies. Going forward, the healthcare sector should be view only at innovation that is essential for inclusive and affordable healthcare, Dr. Rath told Pharmabiz in an email.
However, there is a need to accelerate research in a number of areas. It is here that we see Ayushman Bharat as a great step forward. This needs considerable innovation that can provide evidence based, easily governed, affordable, remotely available healthcare solutions for a large mass of population where capital is already available. Even if there are available solutions for hospitals, it is not built for this, he said.
It is here government can come up with regulatory guidelines where start-ups can easily test their solution, produce qualifying results for approval and can be on-boarded on the Ayushman Bharat market place. This will justify the investment into Ayushman Bharat where every rupee will reach the needy in an efficient manner. The other area is the need in establishment of technology business incubator in medical colleges so that the future generation of health professionals could be trained in digital health technologies. This will ensure increased efficiency in the healthcare system, noted Rath.
Early this week Aster DM announced the setting up of the Aster Innovation and Research Centre in Bengaluru which according to Dr Rath is the valley of east even as the location is maturing as a deep tech startup ecosystem. The new research facility would drive development of healthcare innovations through collaboration upto 80% will be applied research in collaboration with start-ups/ industry or academia partnership. In this segment the intent is to incubate and accelerate newer concepts.
The new digital health space faces a bottle neck in the validation phase. Therefore Aster Innovation and Research Centre will focus on nurturing home-grown research. "Till now we have worked on insulin resistance, sepsis filter and dialysis quality of life enhancer. Now this will translate into market realization. We are in the process of hiring AI, Blockchain, IoT experts, besides a pool of scientists, behavioral economists and IP specialists," he said.
The new age deep tech start-ups need quick prototype, rapid insight and a platform to test scalability. Our unique research platform will help them on-board, stay within regulatory boundary and conduct tests. Our technology team can guide, mentor and co-innovate along with them for wider success. The successful candidates will be supported for long term," said Dr Rath.
Courtesy: http://www.pharmabiz.com/ArticleDetails.aspx?aid=117853&sid=1
The country's research activities are in a phase to translate these IPs to sustainable businesses. This can be done through open innovation in collaborative model. The objective is to position ourselves as a potent catalyst in this changing scenario, he added.
Some of the visible trends that one sights in this space are newer inventions like affordable cloud, connectivity, Internet of Things (IoT) that are making preventive and out-of-hospital care a reality. It is important to note that it should be technically feasible. Appropriate applications of this will make this a business reality too. So far hospitals have been using the technologies. Going forward, the healthcare sector should be view only at innovation that is essential for inclusive and affordable healthcare, Dr. Rath told Pharmabiz in an email.
However, there is a need to accelerate research in a number of areas. It is here that we see Ayushman Bharat as a great step forward. This needs considerable innovation that can provide evidence based, easily governed, affordable, remotely available healthcare solutions for a large mass of population where capital is already available. Even if there are available solutions for hospitals, it is not built for this, he said.
It is here government can come up with regulatory guidelines where start-ups can easily test their solution, produce qualifying results for approval and can be on-boarded on the Ayushman Bharat market place. This will justify the investment into Ayushman Bharat where every rupee will reach the needy in an efficient manner. The other area is the need in establishment of technology business incubator in medical colleges so that the future generation of health professionals could be trained in digital health technologies. This will ensure increased efficiency in the healthcare system, noted Rath.
Early this week Aster DM announced the setting up of the Aster Innovation and Research Centre in Bengaluru which according to Dr Rath is the valley of east even as the location is maturing as a deep tech startup ecosystem. The new research facility would drive development of healthcare innovations through collaboration upto 80% will be applied research in collaboration with start-ups/ industry or academia partnership. In this segment the intent is to incubate and accelerate newer concepts.
The new digital health space faces a bottle neck in the validation phase. Therefore Aster Innovation and Research Centre will focus on nurturing home-grown research. "Till now we have worked on insulin resistance, sepsis filter and dialysis quality of life enhancer. Now this will translate into market realization. We are in the process of hiring AI, Blockchain, IoT experts, besides a pool of scientists, behavioral economists and IP specialists," he said.
The new age deep tech start-ups need quick prototype, rapid insight and a platform to test scalability. Our unique research platform will help them on-board, stay within regulatory boundary and conduct tests. Our technology team can guide, mentor and co-innovate along with them for wider success. The successful candidates will be supported for long term," said Dr Rath.
Courtesy: http://www.pharmabiz.com/ArticleDetails.aspx?aid=117853&sid=1
Good post.Keep on posting!
ReplyDeleteNegosyongPinoy.info